Klausner Richard
SEC CIK 1591178 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | Dir | 843.4K | $94.8K | $203.3K | 3 | 2022-09-23 | 2025-03-14 |
Most active insiders at LYEL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ARCH Venture Partners IX Overage, L.P. | 10% | $12.50M | — |
| 2 | BERNS PAUL L | 10% | $12.50M | — |
| 3 | Seely Lynn | Pres, CEO, Dir | — | $353.1K |
| 4 | Bulis Veronica Sanchez | VP, Corp. Ctrl | — | $96.9K |
| 5 | Lee Gary K. | CSO | — | $71.7K |
| 6 | Hill Stephen J. | COO | — | $51.3K |
| 7 | Shook David | Chief Medical Off | — | $31.3K |
| 8 | Innovative Cellular Therapeutics Holdings Ltd | 10% | — | $274.30 |
Klausner Richard made no open-market trades at LYEL in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-03-18 | 2025-03-14 | LYEL | Lyell Immunopharma, Inc. | Klausner Richard | Dir | P - Purchase | $0.6 | +158.0K | 843.4K | +23% | +$94.8K |
| I | 2023-08-17 | 2023-08-15 | LYEL | Lyell Immunopharma, Inc. | Klausner Richard | Dir | S - Sale | $2.28 | -58.0K | 930.9K | -6% | -$132.3K |
| I | 2022-09-27 | 2022-09-23 | LYEL | Lyell Immunopharma, Inc. | Klausner Richard | Dir | S - Sale | $6.40 | -11.1K | 988.9K | -1% | -$71.0K |
Purchase Sale Sale after option exercise All abbreviations